CI Medical Co Ltd
TSE:3540
Cash Flow Statement
Cash Flow Statement
CI Medical Co Ltd
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
1 866
|
1 892
|
2 149
|
2 862
|
4 451
|
5 076
|
4 285
|
4 245
|
3 851
|
3 426
|
3 184
|
0
|
2 212
|
7 078
|
10 059
|
|
| Depreciation & Amortization |
232
|
265
|
288
|
282
|
272
|
298
|
345
|
367
|
396
|
449
|
1 022
|
1 572
|
1 893
|
2 336
|
1 897
|
|
| Other Non-Cash Items |
80
|
84
|
(30)
|
60
|
313
|
448
|
271
|
52
|
13
|
39
|
(26)
|
0
|
38
|
(4 726)
|
(6 318)
|
|
| Cash Taxes Paid |
712
|
579
|
534
|
673
|
708
|
1 722
|
2 229
|
1 324
|
1 139
|
1 359
|
1 370
|
0
|
1 047
|
949
|
805
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
10
|
18
|
0
|
36
|
68
|
96
|
|
| Change in Working Capital |
(1 456)
|
(1 114)
|
(1 005)
|
(2 731)
|
(876)
|
(1 323)
|
(3 322)
|
(2 585)
|
(2 849)
|
(2 807)
|
(4 319)
|
0
|
(1 210)
|
1 465
|
(937)
|
|
| Cash from Operating Activities |
722
N/A
|
1 127
+56%
|
1 402
+24%
|
473
-66%
|
4 160
+779%
|
4 499
+8%
|
1 579
-65%
|
2 079
+32%
|
1 411
-32%
|
1 107
-22%
|
(139)
N/A
|
411
N/A
|
2 933
+614%
|
6 153
+110%
|
4 701
-24%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(511)
|
(515)
|
(260)
|
(264)
|
(459)
|
(414)
|
(2 831)
|
(6 797)
|
(9 348)
|
(5 684)
|
(8 930)
|
0
|
(9 518)
|
(1 224)
|
(570)
|
|
| Other Items |
(81)
|
(12)
|
5
|
(86)
|
(305)
|
(431)
|
(220)
|
9
|
(701)
|
(745)
|
(865)
|
0
|
(782)
|
(2 881)
|
11 334
|
|
| Cash from Investing Activities |
(591)
N/A
|
(527)
+11%
|
(255)
+52%
|
(350)
-38%
|
(764)
-118%
|
(845)
-11%
|
(3 051)
-261%
|
(6 788)
-122%
|
(10 049)
-48%
|
(6 429)
+36%
|
(9 795)
-52%
|
0
N/A
|
(10 300)
N/A
|
(4 105)
+60%
|
10 764
N/A
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 000
|
7 000
|
0
|
10 100
|
0
|
12 100
|
633
|
(15 721)
|
|
| Cash Paid for Dividends |
(153)
|
(133)
|
(133)
|
(151)
|
(151)
|
(584)
|
(584)
|
(282)
|
(282)
|
(252)
|
(252)
|
0
|
(252)
|
(252)
|
(626)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(8)
|
(12)
|
(23)
|
0
|
(7)
|
(5)
|
(22)
|
|
| Cash from Financing Activities |
(153)
N/A
|
(133)
+13%
|
(133)
0%
|
(151)
-13%
|
(151)
0%
|
(584)
-287%
|
(584)
+0%
|
1 717
N/A
|
6 710
+291%
|
4 736
-29%
|
9 825
+107%
|
0
N/A
|
11 841
N/A
|
376
-97%
|
(16 369)
N/A
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(3)
|
(3)
|
(2)
|
(14)
|
7
|
26
|
10
|
10
|
36
|
76
|
0
|
47
|
1
|
0
|
|
| Net Change in Cash |
(24)
N/A
|
465
N/A
|
1 012
+118%
|
(30)
N/A
|
3 231
N/A
|
3 076
-5%
|
(2 030)
N/A
|
(2 982)
-47%
|
(1 918)
+36%
|
(550)
+71%
|
(33)
+94%
|
517
N/A
|
4 521
+774%
|
2 425
-46%
|
(904)
N/A
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
212
N/A
|
612
+189%
|
1 143
+87%
|
209
-82%
|
3 701
+1 669%
|
4 085
+10%
|
(1 252)
N/A
|
(4 718)
-277%
|
(7 937)
-68%
|
(4 577)
+42%
|
(9 069)
-98%
|
411
N/A
|
(6 585)
N/A
|
4 929
N/A
|
4 131
-16%
|
|